Medical research and development contract army sbir SEQ PH proposal no. A28137 topic A14049 title diagnostic device for norovirus gastroenteritis
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH20C0071
- Awardee
-
Inbios International Inc. UEI CNJNQ1GMSN55
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $961,577
Award facts
- Opportunity
-
- HQ003420ROAAB Solicitation number
- Contract value 100% obligated
- $961,577.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $427,945 | |
| Original award | $533,633 |
About this award
The U.S. Army awarded a $961,577.47 Firm Fixed Price contract to Inbios International Inc., a Seattle-based minority-owned biotechnology company, for the development of a diagnostic device for norovirus gastroenteritis. This Small Business Innovation Research (SBIR) Phase II sequential contract (Proposal No. A28137, Topic A14049) represents Year 2 funding under the Army's 2014.1 SBIR program and was set aside for small business participation. The work was performed in Seattle, Washington, with an ultimate completion date of January 22, 2023. The contract was awarded on September 23, 2020, by the Army Medical Command, reflecting the Department of Defense's investment in advancing rapid diagnostic capabilities for infectious disease detection.
Inbios International has established itself as a critical partner to federal health and defense agencies in the development and manufacture of immunodiagnostic devices. The company's focus on creating innovative diagnostic solutions for infectious diseases aligns with broader government priorities, particularly following the COVID-19 pandemic response efforts. This SBIR contract builds on Inbios's demonstrated expertise in point-of-care diagnostics and its track record of securing substantial federal awards from agencies including the Department of Health and Human Services, the Centers for Disease Control and Prevention, and the National Institute of Allergy and Infectious Diseases for developing advanced diagnostic technologies targeting both emerging and neglected infectious diseases.
Quick answers
Who was awarded contract W81XWH20C0071?
W81XWH20C0071 was awarded to Inbios International Inc. by Medical Command (Department of the Army) on September 23, 2020.
How much is contract W81XWH20C0071 worth?
The government has obligated $961,577 on W81XWH20C0071.
Was contract W81XWH20C0071 competed?
The extent of competition for W81XWH20C0071 was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award